All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Zepbound and Fertility

Zepbound should be stopped at least one month before trying to conceive. Learn how Zepbound affects fertility, its impact on PCOS, contraception...

By Dr. James Walker, MD, MPH|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. James Walker, MD, MPH · Reviewed by Dr. David Kim, MD, FACE

Zepbound and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Zepbound and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Zepbound and Fertility

Zepbound should be stopped at least one month before trying to conceive. Learn how Zepbound affects fertility, its impact on PCOS, contraception...

Short answer

Zepbound should be stopped at least one month before trying to conceive. Learn how Zepbound affects fertility, its impact on PCOS, contraception...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, hormone labs and monitoring

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Zepbound should be stopped at least one month before trying to conceive. Learn how Zepbound affects fertility, its impact on PCOS, contraception advice, and pregnancy planning timelines.

Zepbound (tirzepatide) should be stopped at least one month before attempting pregnancy. The drug isn't approved for use during pregnancy, and the manufacturer advises a washout period to ensure clearance. On the other hand, the substantial weight loss Zepbound delivers may significantly improve fertility for patients with obesity-linked reproductive difficulties.

Zepbound is the weight management formulation of tirzepatide, a dual GIP/GLP-1 receptor agonist. Given that it's prescribed primarily to patients with a BMI of 30 or higher, many of its users are in demographics where fertility planning is a relevant concern.

Discontinuation Timeline for Pregnancy Planning

Tirzepatide has a half-life of roughly five days. After stopping Zepbound, the drug is considered substantially cleared from the body within about four weeks (roughly five to six half-lives). The prescribing information recommends stopping at least one month before planned conception.

Animal studies conducted at supratherapeutic doses revealed adverse developmental outcomes, including reduced fetal weight and skeletal variations. Human pregnancy data remains extremely limited because pregnant patients are excluded from clinical trials. The one-month washout provides a reasonable safety margin based on the drug's pharmacokinetics.

Fertility Benefits of Zepbound-Assisted Weight Loss

Clinical trials for tirzepatide showed weight loss averaging 15% to 25% of starting body weight, among the highest of any medication currently available. For patients whose fertility is impaired by excess weight, this degree of reduction can be genuinely life-changing: Check out our see real Zepbound results for detailed data.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Zepbound and Fertility
  • Ovulation may resume in women who had stopped ovulating due to obesity or PCOS
  • Hormone profiles normalize as excess adipose tissue decreases
  • IVF and IUI success rates improve at lower body weight
  • Pregnancy complications like gestational diabetes and hypertension become less likely
  • Male partners benefit from improved testosterone and sperm quality after weight loss

Unexpected Pregnancies and Contraception

As with other GLP-1 medications, weight loss on Zepbound can restore ovulatory function in women who previously had irregular or absent periods. This has led to unplanned pregnancies in patients who did not expect to conceive. If pregnancy isn't your goal, use dependable contraception throughout treatment.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Zepbound's prescribing information specifically notes that it may affect oral contraceptive absorption due to delayed gastric emptying. Patients using oral birth control are advised to add a backup method for four weeks after initiating Zepbound and for four weeks after each dose increase. Non-oral methods like IUDs, implants, and contraceptive injections aren't impacted.

Frequently Asked Questions

How long should I wait after stopping Zepbound to try to get pregnant?

The manufacturer recommends at least one month between your last Zepbound injection and conception attempts. This allows the drug to clear your system based on its five-day half-life. Your healthcare provider may personalize this timeline depending on your dose and overall health.

Can Zepbound improve fertility?

The weight loss from Zepbound can improve fertility indirectly by restoring hormonal balance, resuming ovulation, and reducing insulin resistance. It isn't a fertility medication, but patients with obesity-related reproductive challenges often see measurable improvements in fertility markers after significant weight loss. Zepbound for weight loss

What if I discover I am pregnant while on Zepbound?

Stop Zepbound right away and reach out to your healthcare provider. Early pregnancy exposure to tirzepatide hasn't been extensively studied in humans. Prompt discontinuation and clinical follow-up are the standard approach.

Does Zepbound affect birth control effectiveness?

Zepbound may reduce oral contraceptive absorption because it delays gastric emptying. The prescribing information recommends using a backup contraceptive method for four weeks after starting Zepbound and after each dose escalation. Non-oral contraceptives aren't affected by this concern. GLP-1 drug interactions

Does Zepbound affect male fertility?

Direct effects of tirzepatide on male fertility haven't been well characterized in human studies. Animal data at standard doses did not reveal significant reproductive harm. For overweight men, the weight loss from Zepbound may improve testosterone and sperm quality, potentially supporting better reproductive outcomes.

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Zepbound evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Zepbound and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2019

GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis

Used for PCOS pages comparing metabolic and weight-management approaches.

PubMed

Systematic reviewPCOS and GLP-1 evidence2024

The efficacy and safety of GLP-1 agonists in PCOS women living with obesity

Supports PCOS, obesity, and hormonal-regulation context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2026

GLP-1 receptor agonist treatment in women with polycystic ovary syndrome

Current review source for pages discussing GLP-1 treatment in PCOS.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Zepbound and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Zepbound should be stopped at least one month before trying to conceive. Learn how Zepbound affects fertility, its impact on PCOS, contraception advice, and pregnancy planning timelines. Before you use "Zepbound and Fertility" to make a real decision, separate the headline answer from the details that could change it. The page connects patient education and clinical context with tirzepatide, inside a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision. Read the opening answer first, then check the evidence and safety sections before acting on the recommendation. Bring anything that changes dosing, pharmacy choice, cost, or safety to a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Zepbound and Fertility

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, testosterone, cash-pay pricing, safety signals so the article stays close to the question behind "Zepbound and Fertility".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Zepbound and Fertility from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Zepbound and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Zepbound and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Zepbound and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. James Walker, MD, MPH

Internal Medicine. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.